Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen

Am J Hematol. 1999 Jan;60(1):70-1. doi: 10.1002/(sici)1096-8652(199901)60:1<70::aid-ajh12>3.0.co;2-d.

Abstract

A rare cause of a spontaneous, life threatening coagulopathy in adults is the development of autoantibodies to factor VIII. We recently had the opportunity to treat seven patients with this disorder. After stabilization, they were given a regimen consisting of prednisone and oral cyclophosphamide. All patients had a complete response to treatment. The median time to response was three weeks. Durable remissions were achieved, making this oral regimen an acceptable treatment for this disorder.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Ambulatory Care
  • Autoantibodies / blood
  • Autoimmune Diseases / drug therapy
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use
  • Drug Combinations
  • Factor VIII / immunology*
  • Female
  • Hemophilia A / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use
  • Remission Induction

Substances

  • Autoantibodies
  • Drug Combinations
  • Cyclophosphamide
  • Factor VIII
  • Prednisone